Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro

被引:239
作者
Baas, P. [1 ,2 ]
Fennell, D. [3 ]
Kerr, K. M. [4 ]
Van Schil, P. E. [5 ]
Haas, R. L. [6 ]
Peters, S. [7 ]
机构
[1] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Leicester, Dept Med Oncol, Leicester, Leics, England
[4] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
[5] Univ Antwerp, Dept Thorac & Vasc Surg, B-2020 Antwerp, Belgium
[6] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[7] CHU Vaudois, Dept Med Oncol, CH-1011 Lausanne, Switzerland
关键词
PEMETREXED PLUS CISPLATIN; PHASE-II TRIAL; MODULATED RADIATION-THERAPY; DOSE HEMITHORACIC RADIATION; EXTRAPLEURAL PNEUMONECTOMY; TRIMODALITY THERAPY; OPEN-LABEL; INTERNATIONAL-ASSOCIATION; CHEMOTHERAPY; MULTICENTER;
D O I
10.1093/annonc/mdv199
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
[No abstract available]
引用
收藏
页码:V31 / V39
页数:9
相关论文
共 57 条
[1]
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma [J].
Allen, AM ;
Czerminska, M ;
Jänne, PA ;
Sugarbaker, DJ ;
Bueno, R ;
Harris, JR ;
Court, L ;
Baldini, EH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03) :640-645
[2]
[Anonymous], WHO CLASSIFICATION T
[3]
Imaging in pleural mesothelioma: A review of the 11th International Conference of the International Mesothelioma Interest Group [J].
Armato, Samuel G., III ;
Labby, Zacariah E. ;
Coolen, Johan ;
Klabatsa, Astero ;
Feigen, Malcolm ;
Persigehl, Thorsten ;
Gill, Ritu R. .
LUNG CANCER, 2013, 82 (02) :190-196
[4]
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation [J].
Baktiar, Hasan ;
Laurent, Greillier ;
Athanasios, Pallis ;
Jessica, Menis ;
Rabab, Gaafar ;
Richard, Sylvester ;
Dean, Fennell A. ;
Paul, Baas ;
Veerle, Surmont ;
Jan, Van Meerbeeck P. ;
Mary, O'brien E. R. .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (16) :2771-2782
[5]
Baldini EH, 1997, ANN THORAC SURG, V63, P334
[6]
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma [J].
Blayney, Jaine K. ;
Ceresoli, Giovanni L. ;
Castagneto, Bruno ;
O'Brien, Mary E. R. ;
Hasan, Baktiar ;
Sylvester, Richard ;
Rudd, Robin ;
Steele, Jeremy ;
Busacca, Sara ;
Porta, Camillo ;
Mutti, Luciano ;
O'Byrne, Kenneth J. ;
Scullin, Paula ;
Gaafar, Rabab ;
Baas, Paul ;
Van Meerbeeck, Jan ;
Fennell, Dean A. .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (16) :2983-2992
[7]
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study [J].
Buikhuisen, Wieneke A. ;
Burgers, Jacobus A. ;
Vincent, Andrew D. ;
Korse, Catharina M. ;
van Klaveren, Rob J. ;
Schramel, Franz M. N. H. ;
Pavlakis, Nick ;
Nowak, Anna K. ;
Custers, Frank L. J. ;
Schouwink, J. Hugo ;
Gans, Steven J. M. ;
Groen, Harry J. M. ;
Strankinga, Wim F. M. ;
Baas, Paul .
LANCET ONCOLOGY, 2013, 14 (06) :543-551
[8]
BUTCHART E G, 1990, Current Opinion in Oncology, V2, P352
[9]
Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial [J].
Calabro, Luana ;
Morra, Aldo ;
Fonsatti, Ester ;
Cutaia, Ornella ;
Amato, Giovanni ;
Giannarelli, Diana ;
Di Giacomo, Anna Maria ;
Danielli, Riccardo ;
Altomonte, Maresa ;
Mutti, Luciano ;
Maio, Michele .
LANCET ONCOLOGY, 2013, 14 (11) :1104-1111
[10]
Systematic review of trimodality therapy for patients with malignant pleural mesothelioma [J].
Cao, Christopher ;
Tian, David ;
Manganas, Con ;
Matthews, Phoebe ;
Yan, Tristan D. .
ANNALS OF CARDIOTHORACIC SURGERY, 2012, 1 (04) :428-437